CompletedEarly Phase 1NCT02694783
Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells
Studying Progressive multifocal leukoencephalopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Principal Investigator
- Irene CM Cortese, M.D.National Institute of Neurological Disorders and Stroke (NINDS)
- Intervention
- PyVST(biological)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2020
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02694783 on ClinicalTrials.govOther trials for Progressive multifocal leukoencephalopathy
Additional recruiting or active studies for the same condition.
See all trials for Progressive multifocal leukoencephalopathy →